Unlocking new modalities
for prostate cancer patients
Developing selective, targeted and first-in-class therapies
Alata
Alice
Open Sans
Noto Sans
Bebas Neue
Great Vibes
Rock Salt
Exo
Belgrano
Overlock
Cinzel
Indie Flower
Staatliches
Roboto Slab
Lato
Noto Serif
Open Sans
Montserrat
Ubuntu
Rubik
Delius
Amiri
Montserrat
small steps towards better health
Selective delivery via PSMA targeting
Harnessing PSMA as a point of entry into prostate cancer cells
Established biological concept
Removing from the cells proteins causing prostate cancer growth
Building tomorrow
Pi-SMA therapeutics is driving the development of new molecules by combining two validated biological concepts
